Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update

PUBLISHED Tuesday, April 28, 2026 · inc., wave life sciences usa

AI BRIEFING

⬤ Wave Life Sciences reports positive FDA acceptance of Phase 2a trial for WVE-007
⬤ Trial remains on track to initiate in 2Q 2026
⬤ Phase 2a trial aims to test INHBE GalNAc-siRNA for type 2 diabetes